Patients with inflammatory diseases such as rheumatoid arthritis or psoriasis have a higher risk of developing Alzheimer’s disease,…
Iqra Mumal, MSc
Iqra holds a MSc in Cellular and Molecular Medicine from the University of Ottawa in Ottawa, Canada. She also holds a BSc in Life Sciences from Queen’s University in Kingston, Canada. Currently, she is completing a PhD in Laboratory Medicine and Pathobiology from the University of Toronto in Toronto, Canada. Her research has ranged from across various disease areas including Alzheimer’s disease, myelodysplastic syndrome, bleeding disorders and rare pediatric brain tumors.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Iqra Mumal, MSc
Antioxidant Compound, with Aid of Baker’s Yeast, May Offer Oral Supplement to Offset Alzheimer’s
A natural compound with antioxidative properties that might help to delay the onset of neurodegenerative diseases like Alzheimer’s can…
A Phase 2b study of oral neflamapimod in treating mild Alzheimer’s disease met its secondary goals of statistically significant drops in…
Antibiotics Altering Gut Bacteria Reduced Alzheimer’s Symptoms, But Only in Male Mice, Study Shows
Long-term antibiotic treatment, aimed at altering the bacterial population in the gut, was found to reduce the inflammation and…
African-Americans have lower expression of two biomarkers of Alzheimer’s, suggesting a possible race-dependent biological mechanism that contributes to the…
Deep learning, a type of artificial intelligence, used brain imaging scans to predict — years in advance and with nearly…
Essential oils derived from different plant species have revealed encouraging clinical and preclinical results to reverse cognitive and memory impairments…
High levels of free triiodothyronine — a type of thyroid hormone — are associated with a lower rate of Alzheimer’s disease risk…
New Strategy May Help Identify Those with Mild Cognitive Impairment at Risk to Develop Alzheimer’s
A newly developed strategy may help researchers identify which people with mild cognitive impairment are likely to develop Alzheimer’s disease. The…
ProMIS’ PMN310 Shows Improved Safety Profile, Specificity Compared to Similar Alzheimer’s Candidates
ProMIS Neurosciences’ lead therapeutic candidate for Alzheimer’s disease, PMN310, showed an improved safety profile when directly compared to…